These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 11074212)
1. Effect of preoperative statin therapy and cardiac outcomes after coronary artery bypass grafting. Dotani MI; Elnicki DM; Jain AC; Gibson CM Am J Cardiol; 2000 Nov; 86(10):1128-30, A6. PubMed ID: 11074212 [TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness analysis of cholesterol-lowering therapies in Spain. Plans-Rubió P Am J Cardiovasc Drugs; 2006; 6(3):177-88. PubMed ID: 16780391 [TBL] [Abstract][Full Text] [Related]
3. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice. Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658 [TBL] [Abstract][Full Text] [Related]
4. Preoperative statin therapy and troponin T predict early complications of coronary artery surgery. Pascual DA; Arribas JM; Tornel PL; Marín F; Oliver C; Ahumada M; Gomez-Plana J; Martínez P; Arcas R; Valdes M Ann Thorac Surg; 2006 Jan; 81(1):78-83. PubMed ID: 16368340 [TBL] [Abstract][Full Text] [Related]
5. Differential effects of lipid-lowering therapies on stroke prevention: a meta-analysis of randomized trials. Corvol JC; Bouzamondo A; Sirol M; Hulot JS; Sanchez P; Lechat P Arch Intern Med; 2003 Mar; 163(6):669-76. PubMed ID: 12639199 [TBL] [Abstract][Full Text] [Related]
6. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study). Pincus J Am J Cardiol; 1998 Aug; 82(3):406-7. PubMed ID: 9708683 [No Abstract] [Full Text] [Related]
7. Comparison of efficacy and safety of atorvastatin (80 mg) to simvastatin (20 to 40 mg) in patients aged <65 versus >or=65 years with coronary heart disease (from the Incremental DEcrease through Aggressive Lipid Lowering [IDEAL] study). Tikkanen MJ; Holme I; Cater NB; Szarek M; Faergeman O; Kastelein JJ; Olsson AG; Larsen ML; Lindahl C; Pedersen TR; Am J Cardiol; 2009 Mar; 103(5):577-82. PubMed ID: 19231315 [TBL] [Abstract][Full Text] [Related]
8. Outcomes of patients with acute coronary syndrome and previous coronary artery bypass grafting (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy [PROVE IT-TIMI 22] and the Aggrastat to Zocor [A to Z] trials). Brilakis ES; de Lemos JA; Cannon CP; Wiviott SD; Murphy SA; Morrow DA; Sabatine MS; Banerjee S; Blazing MA; Califf RM; Braunwald E Am J Cardiol; 2008 Sep; 102(5):552-8. PubMed ID: 18721511 [TBL] [Abstract][Full Text] [Related]
9. Effect of statin therapy on restenosis after coronary stent implantation. Walter DH; Schächinger V; Elsner M; Mach S; Auch-Schwelk W; Zeiher AM Am J Cardiol; 2000 Apr; 85(8):962-8. PubMed ID: 10760335 [TBL] [Abstract][Full Text] [Related]
10. Atorvastatin versus simvastatin. Calder RA Am J Cardiol; 1997 Dec; 80(12):1646. PubMed ID: 9416964 [No Abstract] [Full Text] [Related]
11. Safety and efficacy of ezetimibe/simvastatin combination versus atorvastatin alone in adults ≥65 years of age with hypercholesterolemia and with or at moderately high/high risk for coronary heart disease (the VYTELD study). Foody JM; Brown WV; Zieve F; Adewale AJ; Flaim D; Lowe RS; Jones-Burton C; Tershakovec AM Am J Cardiol; 2010 Nov; 106(9):1255-63. PubMed ID: 21029821 [TBL] [Abstract][Full Text] [Related]
12. Rationale and design of the Myocardial Ischemia Reduction With Aggressive Cholesterol lowering (MIRACL) Study that evaluates atorvastatin in unstable angina pectoris and in non-Q-wave acute myocardial infarction. Ghali JK Am J Cardiol; 1998 Sep; 82(5):703. PubMed ID: 9732912 [No Abstract] [Full Text] [Related]
13. The cost of reaching National Cholesterol Education Program (NCEP) goals in hypercholesterolaemic patients. A comparison of atorvastatin, simvastatin, lovastatin and fluvastatin. Koren MJ; Smith DG; Hunninghake DB; Davidson MH; McKenney JM; Weiss SR; Schrott HG; Henley RW; Tresh P; McLain RW; Bakker-Arkema RG; Black DM Pharmacoeconomics; 1998 Jul; 14(1):59-70. PubMed ID: 10182195 [TBL] [Abstract][Full Text] [Related]
15. [Substantiation of increasing doses of statins in clinical practice]. Susekov AV Ter Arkh; 2001; 73(4):76-80. PubMed ID: 11494456 [No Abstract] [Full Text] [Related]
16. Low density lipoprotein-cholesterol variability in patients with type 2 diabetes taking atorvastatin compared to simvastatin: justification for direct measurement? Sathyapalan T; Atkin SL; Kilpatrick ES Diabetes Obes Metab; 2010 Jun; 12(6):540-4. PubMed ID: 20518809 [TBL] [Abstract][Full Text] [Related]
17. Atorvastatin: gold standard for prophylaxis of myocardial ischemia and stroke - comparison of the clinical benefit of statins on the basis of randomized controlled endpoint studies. Gresser U; Gathof BS Eur J Med Res; 2004 Jan; 9(1):1-17. PubMed ID: 14766335 [TBL] [Abstract][Full Text] [Related]
18. The statin trials: closing arguments in the case against cholesterol? Gaw A Scott Med J; 1996 Aug; 41(4):99-100. PubMed ID: 8873306 [No Abstract] [Full Text] [Related]
19. Lipid-altering efficacy and safety of ezetimibe/simvastatin versus atorvastatin in patients with hypercholesterolemia and the metabolic syndrome (from the VYMET study). Robinson JG; Ballantyne CM; Grundy SM; Hsueh WA; Parving HH; Rosen JB; Adewale AJ; Polis AB; Tomassini JE; Tershakovec AM Am J Cardiol; 2009 Jun; 103(12):1694-702. PubMed ID: 19539078 [TBL] [Abstract][Full Text] [Related]
20. A multicenter, double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients with hypercholesterolemia. Dart A; Jerums G; Nicholson G; d'Emden M; Hamilton-Craig I; Tallis G; Best J; West M; Sullivan D; Bracs P; Black D Am J Cardiol; 1997 Jul; 80(1):39-44. PubMed ID: 9205017 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]